When you’re looking to position therapeutics against alternatives, it pays to know what matters most to stakeholders
Sorting through the vast increase in Real World Evidence has become an overwhelming task — physicians, payers, and healthcare providers are struggling with data overload.
A new company with a broader mission and product set, the name Pharmaspectra better communicates our goal of solving problems across the biopharma spectrum, from drug discovery through post-marketing.
Technology can help MSLs to quickly unearth new data, in real time, gaining the ability to quickly see trends and patterns that can make a difference in the engagements with experts. Here are six best practices to help you save time and achieve greater impact.
For too long Medical Affairs teams have been constrained, forced to base decisions on other departments’ metrics augmented by their own instincts and experiences. Making objective, data-driven decisions have been difficult, if not impossible